Evidence map›Paper›PMID 37164583›Full record

ArticleChest2023

The Shunt of It.

Brittany M Scarpato, Jamie McDonald, Pinar Bayrak-Toydemir, C Gregory Elliott, Barbara C Cahill, Lyska L Emerson, Lynn M Keenan

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Chest, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.4field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. A novelJournal of cardiology cases · 2025
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brittany M ScarpatoDivision of Pulmonary and Critical Care Medicine, University of Utah Hospital, Salt Lake City, UT; Division of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT. Electronic address: brittany.scarpato@hsc.utah.edu.
Jamie McDonaldDepartment of Pathology, University of Utah Hospital, Salt Lake City, UT.
Pinar Bayrak-ToydemirDepartment of Pathology, University of Utah Hospital, Salt Lake City, UT.
C Gregory ElliottDivision of Pulmonary and Critical Care Medicine, Intermountain Medical Center, Murray, UT; Pulmonary Hypertension Care Center, Intermountain Medical Center, Murray, UT.
Barbara C CahillDivision of Pulmonary and Critical Care Medicine, University of Utah Hospital, Salt Lake City, UT.
Lyska L EmersonDepartment of Pathology, University of Utah Hospital, Salt Lake City, UT.
Lynn M KeenanDivision of Pulmonary and Critical Care Medicine, University of Utah Hospital, Salt Lake City, UT; Division of Pulmonary and Critical Care Medicine, George E. Wahlen Department of Veterans Affairs Medical Center, Salt Lake City, UT.
University of Utah Hospital · USIntermountain Medical Center · US

Funding

Multidisciplinary Pulmonary and Critical Care Training ProgramT32HL105321 · NHLBI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Ramsey Hachem, Robert Paine · 2010 to 2026
$4.5M
NHLBI NIH HHS T32 HL105321
6 · The paper itself

Abstract

Pulmonary arteriovenous malformations (PAVMs) are rare and most often identified in patients with hereditary hemorrhagic telangiectasia (HHT). We describe a patient with severe hypoxemia and orthodeoxia with imaging findings consistent with PAVMs. Resected lung pathologic findings confirmed the presence of numerous microscopic vascular abnormalities within the right lower lobe that was consistent with diffuse pulmonary arteriovenous shunts. Family history was negative for HHT but was positive for pulmonary arterial hypertension (PAH) in two second-degree relatives. A vascular malformation gene panel was negative for genes that commonly are associated with HHT but identified a pathogenic variant in the gene encoding bone morphogenetic protein receptor-2 (BMPR2 p.Cys123∗). Pathogenic variants in BMPR2 are a well-known cause of hereditary PAH; there have been several reports to date of patients with PAVMs and PAH. However, this is the first patient to be reported with a pathogenic variant in BMPR2 to have PAVMs in isolation.

Indexed as

Arteriovenous FistulaArteriovenous MalformationsPulmonary Arterial HypertensionPulmonary VeinsTelangiectasia, Hereditary HemorrhagicFamilial Primary Pulmonary HypertensionHumansLungPulmonary Arterybone morphogenetic protein receptor-2pulmonary arterial hypertensionpulmonary arteriovenous malformationshuntvariant

Identifiers

PMID37164583
PMCPMC10206509
OpenAlexW4375862860

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.